HomeDARE • NASDAQ
Dare Bioscience Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 25.43K | 173.35% |
Operating expense | 4.61M | -23.21% |
Net income | -4.38M | 35.19% |
Net profit margin | -17.22K | 76.29% |
Earnings per share | -0.50 | 40.48% |
EBITDA | -4.42M | 26.43% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.33M | 184.52% |
Total assets | 18.62M | 43.08% |
Total liabilities | 28.18M | 17.37% |
Total equity | -9.56M | — |
Shares outstanding | 8.85M | — |
Price to book | -2.67 | — |
Return on assets | -56.25% | — |
Return on capital | 214.07% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.38M | 35.19% |
Cash from operations | -5.47M | 19.70% |
Cash from investing | -157.33K | -2,056.40% |
Cash from financing | 246.58K | 1,657.25% |
Net change in cash | -5.37M | 21.58% |
Free cash flow | -3.78M | 26.96% |
Previous close
$2.88
Day range
$2.88 - $2.92
Year range
$2.67 - $7.56
Market cap
25.58M USD
Avg Volume
14.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2005
Headquarters
Website
Employees
21
